Advertisement

Topics

Enabling efficiency in TB

13:06 EDT 4 Aug 2017 | BioCentury

If qualified, Otsuka's sputum LAM biomarker could improve the efficiencies of adaptive, seamless and/or platform trials in TB.

Original Article: Enabling efficiency in TB

NEXT ARTICLE

More From BioPortfolio on "Enabling efficiency in TB"

Quick Search
Advertisement